This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Validation of an O-GlcNAcase inhibitor as a novel therapeutic agent against Alzheimer pathology
Validation of an O-GlcNAcase inhibitor as a novel therapeutic agent against Alzheimer pathology Investments < €500k United Kingdom 2016
